Armenian government approves $100 million loan agreement with ADB

YEREVAN, Oct. 27. /ARKA/. A $100 million loan agreement between Armenia and the Asian Development Bank was among the non-negotiated bills approved by the government of Armenia at Thursday’s meeting.

The government wants to use the money to finance the 2022 budget deficit. “Therefore, timely receipt of credit funds is of great importance in terms of financing the expenditures provided for by the state budget,” the government said.

Armenia’s 2022 state budget calls for 1 trillion 947.8 billion drams in revenues (17% more compared to 2021) and 2 trillion 184 bln. drams in spending (10% more than last year’s figure).

The state budget deficit is projected at 236.2 billion drams, GDP growth is projected at 7%. -0-

spot_img

POPULAR

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

US dollar and ruble drop against Armenian dram      

YEREVAN, August 17. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market, fell by 0.32 points on August 17, 2026, compared to August 14, to 365.82 drams.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img